Abstract:Background: The accumulation and aggregation of Aβ as amyloid plaques, the hallmark pathology of the Alzheimer.s disease, has been found in other neurological disorders, such as traumatic brain injury. The axonal injury may contribute to the formation of Aβ plaques. Studies to date have focused on the brain, with no investigations of spinal cord, although brain and cord share the same cellular components. Objective: We utilized a spinal cord transection model to examine whether spinal cord injury acutely induced the onset or promote the progression of Aβ plaque 3 days after injury in TgCRND8 transgenic model of AD. Methods: Spinal cord transection was performed in TgCRND8 mice and its littermate control wild type mice at the age of 3 and 20 months. Immunohistochemical reactions/ELISA assay were used to determine the extent of axonal damage and occurrence/alteration of Aβ plaques or levels of Aβ at different ages in the spinal cord of TgCRND8 mice. Results: After injury, widespread axonal pathology indicated by intra-axonal co-accumulations of APP and its product, Aβ, was observed in perilesional region of the spinal cord in the TgCRND8 mice at the age of 3 and 20 months, as compared to age-matched non-TgCRND8 mice. However, no Aβ plaques were found in the TgCRND8 mice at the age of 3 months. The 20-month-old TgCRND8 mice with established amyloidosis in spinal cord had a reduction rather than increase in plaque burden at the lesion site compared to the tissue adjacent to the injured area and corresponding area in sham mice following spinal cord transection. The lesion site of spinal cord area was occupied by CD68 positive macrophages/ activated microglia in injured mice compared to sham animals. These results indicate that spinal cord injury does not induce the acute onset and progression of Aβ plaque deposition in the spinal cord of TgCRND8 mice. Conversely, it induces the regression of Aβ plaque deposition in TgCRND8 mice. Conclusion: The findings underscore the dependence of traumatic axonal injury in governing acute Aβ plaque formation and provide evidence that Aβ plaque pathology may not play a role in secondary injury cascades following spinal cord injury.

Origins of Beta Amyloid Differ Between Vascular Amyloid Deposition and Parenchymal Amyloid Plaques in the Spinal Cord of a Mouse Model of Alzheimer's Disease.

Intracisternal Injection of Beta-Amyloid Seeds Promotes Cerebral Amyloid Angiopathy

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Association Between Axonopathy and Amyloid Plaques in the Spinal Cord of the Transgenic Mice of Alzheimer's Disease

O4‐02‐01: A Novel Role of Beta‐secretase1 (BACE1) in the Pathogenesis of Cerebral Amyloid Angiopathy (CAA)

Amyloid Pathology In Spinal Cord Of The Transgenic Alzheimer'S Disease Mice Is Correlated To The Corticospinal Tract Pathway

The Effect of Spinal Cord Injury on Beta-Amyloid Plaque Pathology in TgCRND8 Mouse Model of Alzheimer’s Disease

Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-Beta Peptide, Partial Restoration Via Gamma-Secretase Inhibition

A Novel Role Of Beta-Secretase 1 (Bace1) In The Pathogenesis Of Cerebral Amyloid Angiopathy (Caa)

Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-β from the mouse brain

Existence of Different Types of Senile Plaques Between Brain and Spinal Cord of TgCRND8 Mice

Beta-Secretase-1 Elevation In Transgenic Mouse Models Of Alzheimer'S Disease Is Associated With Synaptic/Axonal Pathology And Amyloidogenesis: Implications For Neuritic Plaque Development

Temporal Influence of CAA on Cerebrovascular and White Matter Integrity in Parallel with Cognition in Tg-SwDI Mice

Amyloid Plaque Pathogenesis in 5XFAD Mouse Spinal Cord: Retrograde Transneuronal Modulation after Peripheral Nerve Injury

Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow

BACE1 Elevation is Involved in Amyloid Plaque Development in the Triple Transgenic Model of Alzheimer's Disease: Differential Aβ Antibody Labeling of Early-Onset Axon Terminal Pathology.

Identification of Post-Translational Modifications of Aβ Peptide in Platelet Membranes from Patients with Cerebral Amyloid Angiopathy

Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy

Differences in the cerebral amyloid angiopathy proteome in Alzheimer's disease and mild cognitive impairment

Vascular Heparan Sulfate and Amyloid-β in Alzheimer's Disease Patients

Β‐secretase‐1 Elevation in Transgenic Mouse Models of Alzheimer’s Disease is Associated with Synaptic/axonal Pathology and Amyloidogenesis: Implications for Neuritic Plaque Development